Robert Hoffman

2019

In 2019, Robert Hoffman earned a total compensation of $2M as Chief Financial Officer and Senior Vice President, Finance at Heron Therapeutics, a 18% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$124,388
Option Awards$1,512,730
Salary$388,714
Other$8,400
Total$2,034,232

Hoffman received $1.5M in option awards, accounting for 74% of the total pay in 2019.

Hoffman also received $124.4K in non-equity incentive plan, $388.7K in salary and $8.4K in other compensation.

Rankings

In 2019, Robert Hoffman's compensation ranked 5,833rd out of 13,971 executives tracked by ExecPay. In other words, Hoffman earned more than 58.2% of executives.

ClassificationRankingPercentile
All
5,833
out of 13,971
58th
Division
Manufacturing
2,186
out of 5,701
62nd
Major group
Chemicals And Allied Products
789
out of 2,200
64th
Industry group
Drugs
664
out of 1,886
65th
Industry
Pharmaceutical Preparations
488
out of 1,398
65th

Pay ratio

Robert Hoffman's Pay$2,034,232
Median Employee's Pay$408,623
Pay Ratio

5

to 1

In 2019, the annual total compensation of Robert Hoffman was $2,034,232.

The annual total compensation of the median employee at Heron Therapeutics was $408,623.

The ratio of Robert Hoffman's pay to the pay of median employee was therefore 5 to one.

Source: SEC filing on April 23, 2020.

Hoffman's colleagues

We found four more compensation records of executives who worked with Robert Hoffman at Heron Therapeutics in 2019.

2019

Barry Quart

Heron Therapeutics

Chief Executive Officer

2019

John Poyhonen

Heron Therapeutics

Executive Vice President, Chief Commercial Officer

2019

Kimberly Manhard

Heron Therapeutics

Executive Vice President, Drug Development

2019

Robert Rosen

Heron Therapeutics

Former President

News

In-depth

You may also like